MedPath

Cross-sectional study on metabolic fate determination of brown adipose tissue and its impact on energy homeostasis

Not Applicable
Conditions
Healthy adult volunteers
Registration Number
JPRN-UMIN000053934
Lead Sponsor
Tohoku University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
1200
Inclusion Criteria

Not provided

Exclusion Criteria

<FDG-PET/CT> 1. Individuals with dysfunction of liver, renal, cardiovascular, respiratory, endocrine and nervous systems, or with metabolic disorders, diabetes, consciousness disorders or other disease. 2. Individuals who regularly take medications for diabetes, hyperlipidemia or hypertension. 3. Individuals who smoke over 21 cigarettes a day or consume alcohol more than 30g a day on average. 4. Individuals who are pregnant or breastfeeding 5. Individuals who are considered unsuitable for the study by investigators or medical doctor due to other reasons. <NIR-TRS> 1. Individuals with glucose intolerance, hyperlipidemia, hypertension, hyperuricemia/gout, coronary artery disease, cerebral infarction, non-alcoholic fatty liver disease, menstrual disorder, sleep apnea syndrome, motor system disease, obesity-related kidney disease or cardiovascular risk. 2. Individuals with BMI 30 kg/m^2 or more. 3. Individuals with visceral fat area over 100cm^2. 4. Individuals who are considered unsuitable for the study by investigators or medical doctor due to other reasons. <Epigenome> 1. Individuals with dysfunction of liver, renal, cardiovascular, respiratory, endocrine and nervous systems, or with metabolic disorders, diabetes, consciousness disorders or other disease. 2. Individuals who regularly take medications for diabetes, hyperlipidemia or hypertension. 3. Individuals who smoke over 21 cigarettes a day or consume alcohol more than 30g a day on average. 4. Female. 5. Individuals who are considered unsuitable for the study by the investigators due to other reasons.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath